OUR MISSION

Cardiovascular related medical complications are some of the most severely diagnosed conditions by physicians. Upwards of five million Americans are diagnosed with heart valve disease each year. Heart valve disease is the malfunction of any of the four valves found within the human heart, and can be developed through other health conditions such as high blood pressure, atherosclerosis, and rheumatic fever.

Our system will replace current models used to train physicians for transfemoral and transseptal surgeries. Currently, the only method for testing preliminary heart valve devices is through the use of a live animal model, particularly porcine. However, there’s always the possibility that the animal will die prematurely due to cardiac arrest, eliminating the possibility of postoperative data and monitoring. Using live animals for testing and training can cost upwards of $10,000.

By characterizing the mechanical aspects of the heart and simulating transfemoral and transseptal approaches, there exists great potential for testing and developing artificial heart valves. Our model will provide a solution to cardiovascular health issues within the medical field. It will also offer proper physician training and serve to investigate further development of transcatheter heart valve design and insertion.

PRODUCTS

DESIGN DETAILS

APPROACH

The innovative approaches and elements our team used includes:

• Solidworks: used to design and conjure the various components
• Suction cups: holds fixtures in place and provides stability.
• 3D Printing: used to physically create the beating heart model fixtures.
• Modularity: to assist in the replacement and improve the usability of hearts; increase portability

Our technology was designed for physicians, surgeons, and engineers with maximum efficiency and affordability as a top priority. Its portability, ease of use, and cost effectiveness set it apart from the current standard, while also removing the need for animal models.

Current Competitors

Cardiac Biosimulator Platform by LifeTec Group

LifeTec Group manufactures a competitive beating heart model that produces realistic biosimulation. Unfortunately, this model is restricted to a single training facility due to its size and complex nature. Unlike the Cardiac Biosimulator Platform, BeatBox is highly portable, modular, and plug-and-play allowing physicians to train in transcatheter procedures at their practicing facility.

MARKET STRATEGY

Potential Market Breadown

Our Total Available Market includes the entirety of the heart valve market at $8.86 billion. Followed by our Serviceable Available Market which is the mitral valve market at $1.5 Billion. Finally, our Serviceable Obtainable Market encompasses the mitral valve research market at $234 million.

Beatbox technology is marketed towards companies, hospitals, or medical schools that are in need of a more efficient way to study and train their constituents on transcatheter insertion.

Clients have the option of paying by each use, a monthly subscription with limited uses per month or a lifetime fee that would allow for unlimited use of the product according to availability. Contact us for pricing and availability!

ABOUT US